Showing results (731-740 of 742) with videos related to
Sort By:
Pageof 75
Nature Immunology|August 4, 2016
CXCR5(+) follicular cytotoxic T cells control viral infection in B cell folliclesYew Ann Leong, Yaping Chen, Hong Sheng Ong, et al.Neuron|February 13, 2018
Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent ExcitabilityJohn M Dawes, Greg A Weir, Steven J Middleton, et al.Ebiomedicine|May 6, 2023
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccineGeorgia Deliyannis, Nicholas A Gherardin, Chinn Yi Wong, et al.Nature Communications|July 17, 2021
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIVJeffrey V Lazarus, Kelly Safreed-Harmon, Adeeba Kamarulzaman, et al.Ebiomedicine|November 28, 2023
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose boosterTerry M Nolan, Georgia Deliyannis, Maryanne Griffith, et al.Proceedings of the National Academy of Sciences of the United States of America|September 16, 2024
SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 yearsLouise C Rowntree, Jennifer Audsley, Lilith F Allen, et al.Cell Reports. Medicine|February 10, 2021
Integrated immune dynamics define correlates of COVID-19 severity and antibody responsesMarios Koutsakos, Louise C Rowntree, Luca Hensen, et al.Nature Medicine|July 12, 2016
International AIDS Society global scientific strategy: towards an HIV cure 2016Steven G Deeks, Sharon R Lewin, Anna Laura Ross, et al.Proceedings of the National Academy of Sciences of the United States of America|September 2, 2025
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypesLouise C Rowntree, Lilith F Allen, Ruth R Hagen, et al.NEJM Evidence|February 6, 2024
A Randomized Trial of Nafamostat for Covid-19Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.Pageof 75